GLP-1 Receptor

Other GPCR & G Protein Related Inhibitors

Hedgehog/Smoothened PKA CGRP Receptor Endothelin Receptor S1P Receptor Cannabinoid Receptor SGLT Opioid Receptor GPR CCR

Cat.No.	Product Name	Information	Product Use Citations
S8256	Liraglutide	Liraglutide is a long-acting glucagon-like peptide-1(GLP-1) receptor agonist.	Cell Rep Med, 2025, 6(6):102156 Cancers (Basel), 2025, 17(4)598 J Immunother Cancer, 2024, 12(3)e008431
S9851	Danuglipron (PF-06882961)	Danuglipron (PF-06882961) is a non-peptide agonist that activates the canonical G protein signaling activity only in the Glucagon-like peptide-1 (GLP-1) receptor with Trp33^ECD.
E1827	AZD5004 (ECC5004)	ECC5004(AZD5004, GLP-1 agonist (Eccogene)) is a small molecule GLP-1 receptor agonist (GLP-1RA) used to treat digestive system diseases and endocrine and metabolic diseases. ECC5004 has the potential to be used to treat obesity, type 2 diabetes and metabolic dysfunction-associated steatohepatitis (MASH) disease.

Cat.No.

Product Name

Information

Product Use Citations

Product Validations

S8256

Liraglutide

Liraglutide is a long-acting glucagon-like peptide-1(GLP-1) receptor agonist.

Cell Rep Med, 2025, 6(6):102156

Cancers (Basel), 2025, 17(4)598

J Immunother Cancer, 2024, 12(3)e008431

S9851

Danuglipron (PF-06882961)

Danuglipron (PF-06882961) is a non-peptide agonist that activates the canonical G protein signaling activity only in the Glucagon-like peptide-1 (GLP-1) receptor with Trp33^ECD.

E1827

AZD5004 (ECC5004)

ECC5004(AZD5004, GLP-1 agonist (Eccogene)) is a small molecule GLP-1 receptor agonist (GLP-1RA) used to treat digestive system diseases and endocrine and metabolic diseases. ECC5004 has the potential to be used to treat obesity, type 2 diabetes and metabolic dysfunction-associated steatohepatitis (MASH) disease.